(123)i-meta-iodobenzylguanidine
(123)i-mibg
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
2-vessel cad
2-way anova
3-vessel cad
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
8-fluo-camp
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
abcc2
abcd classification
ablation
absorptiometry
acetylcholinesterase inhibitor
acute rv failure
adenoviral
adjusted odds ratio
adjuvant
adrenergic
adrenomedullin
adverse event
adverse events
adverse outcome
adverse outcomes
aetiologies
akt→forkhead box class o-1 signaling
alberta
aldactone
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmissions
allogeneic
ambulatory
amino-terminal pro-b-type natriuretic peptide
amyloidotic
anabolic
anastomosis
anesthetized
ang ii
angeli's salt
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme inhibitors
angiotensin ii  infusion
angiotensin receptor antagonist
angiotensin receptors blockers
angiotensin-converting enzyme
angiotensin-receptor neprilysin inhibitors
antagomir
antagonism
antagonist
antagonists
anterior leaflet
anti-inflammatory
antiadrenergic
antiarrhythmic
antitumor
aortic
aortic insufficiency
aortic pressure
apex
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arni inhibitors
arterial
arteries
artery
artery tonometry
arthritis
asymptomatic
at1
atherosclerosis risk in communities
atherosclerotic
atpase
atrial
atrial explants
atrioventricular
atrium
attrition
auscultation
autologous
autonomic nervous system
b natriuretic peptides
b-type natriuretic peptides
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
barriers to exercise score
basic helix-loop-helix
benign tumors
biomedical
biopsies
biopsy
blood
blood cell
blood flow
blood glucose
bolus
bone morphogenetic protein 4
bpm
bradycardic
brain
bromodomain
bromodomain-containing protein 4
btt
bundle branch block
bundle branch morphology
bypass
c statistics
c termini
c'd
c-kit+ cell
c-kit+ cells
c-kit+ progenitors
c-terminally
ca(2+)
ca(2+) handling
ca(2+) sensitivity
ca2(+)
ca2+
california
california office of statewide health planning and development patient discharge data nonpublic file
camp signaling
canada
candesartan
candesartan in heart failure assessment of reduction in mortality and morbidity
carcinoma
cardiac defibrillator
cardiac energy metabolism gene expression
cardiac event
cardiac magnetic resonance postcontrast t1 time
cardiac metabolic gene expression
cardiac overexpression
cardiac progenitor function
cardiac sodium
cardiac transplants
cardiac volume
cardiac volume overload
cardiac washout
cardiogenic
cardiography
cardiology-cardiovascular surgery consensus report
cardiomyiopathy
cardiomyocyte
cardiomyopathic
cardiopulmonary
cardiopulmonary exercise test
cardiovascular function
cardiovascular outcomes in renal atherosclerotic lesions
cardioverter defibrillators
cardioverter-defibrillator
cardioverter-defibrillator device
carotid intima-media thickness
case-fatality rate
caspase 3
catabolic
catecholamine
catecholamines
catheter
catheterisation
cd133+ cells
cd34+vegfr2+ cells
cell adhesion genes
cell death
cells
cellular metabolism
central glycosylated region
centre for reviews and dissemination
cerebral
cerebrovascular
cfi
cgmp synthesis
chagas' disease
chamber
charm
cha₂ds₂vasc score
chest
chronic
chronic acf
chronic hfpef
chronic pah
chronic thromboembolic pulmonary hypertension
chronotropic response
ci
circulatory
circumflex artery
citrate cycle
clcnka
clinic
clinical practice guidelines
clinically
clinician
clinicians
clinics
cluster analysis
co-morbidity
co-primary outcome
cochrane
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
collins
combined end point
comorbid
comorbidity
compensated hfpef
compensated lv hypertrophy
compliance
composite end point
composite end-point
composite primary outcome
concentric left ventricular hypertrophy
condition
confirmatory factor analysis
congenital
connecticut
contemporaneous control group
contractile response
contracting
coprimary outcome
coronary
coronary artery bypass
coronary artery calcium scores
correlate
correlated
correlates
correlation
correlations
covariate
covariate adjustment
covariates
cox modeling
cox proportional hazard analyses
cox proportional hazard models
cox proportional hazards analyses
cox proportional hazards models
cox proportional hazards regression modeling
cox regression analysis
cpg
creatine
cronbach's α
cross talk
crossover study
curative
cyclase
cyclic adenosine monophosphate
cytochrome c
cytoskeleton
cytotoxic
dapc protein
dash/srd
deaths
decompensated heart failure
decompensated hf
decompensation
defibrillation
defibrillators
denervation
descriptive statistics
dhand
diabetic
diagnosed
diagnoses
diagnosis
diagnostic
diastolic filling formalism
diastolic mitral annulus velocity
diastolic mitral leaflet motions
differential analysis
differential effect
differentially expressed genes
dilatation
dilated
dilated lv
dilation
discharges
diseased
diseases
donors
doppler mitral inflow velocity
double-blind
downregulated
downstream signaling
downstream signalling
dpp-4
driveline
drug
drug treatment
dual x-ray absorptiometry
e/e'
early treatment of atrial fibrillation for stroke prevention trial
echo-doppler
effector molecules
electrocardiogram
electrocardiographic q waves
embolectomy
embolism
embolize
emergency room
end point
end points
end-point
end-stage hf
end-systolic
endopeptidase
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
eo-cfu
ephesus
epidemic
epidemiology
epigenetic
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
estimated glomerular filtration rate
etiologies
etiology
euthanization
evidence based practice centres
evidence-based
exercise oscillatory ventilation
exercise tolerance
explant
explanted
explants
exploratory factor analysis
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extra corporeal membrane oxygenation
extracellular
extracellular flux analyzer
extracorporeal support
fat-free mass
fibrillation
fluid overload
fluorescence resonance energy transfer
follow up
follow-up duration
followed up
followed-up
free wall cs
free wall rs
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
fully magnetically levitated lvas
functional class
functional electrical stimulation
functional enrichment analysis
functional status
g-protein-coupled receptor
gadolinium-chelate
gastrointestinal
gata4
gem/kir
gene
gene expression profile
gene expressions
gene induction
general anaesthesia
genes
genomic
genotype
genotyped
get with the guideline-heart failure registry
get with the guidelines-heart failure
global gene expression
global left ventricular longitudinal systolic strain
gls
glucocorticoids
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
gtpase
guideline-directed medical therapy
haematopoietic
haplotype
hazard ratios
health care
health-care
healthcare
healthy
heart  failure
heart failure - a controlled trial investigating outcomes in exercise training
heart failure adherence and retention trial
heart failure and reduced ejection fraction
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart muscle
heart sound
heart-specific irs1 and irs2 gene double-knockout
heartmate ii
hemodynamic phenotype
hemodynamics
hemostasis
hepatic
hereditary
heterochromatic chromatin
hf index
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
hhd
histologically
hm ii
homozygous
hospital anxiety and depression scale
hospital compare
hospitalisation
hospitalisations
hospitalizations
hrv
human embryonic kidney
human induced pluripotent stem cell-derived cardiomyocytes
human-to-human contact
hypertensive
hypertensive heart failure with preserved ejection fraction
hypertensive hfpef
hypertrophic
hypertrophied
hypothermic circulatory arrest
idiopathic
immunoreactive
implantable
implantable cardioverter defibrillator
implantable cardioverter-defibrillators
implantable defibrillators
implants
in vitro
in vivo coronary perfusion
incidence
incremental shuttle walk test
infarcted
infarction
infection
infusions
ingenuity pathway analysis
inhospital
injected
inoperable
insignificantly
insulin receptor substrates 1
insulin-resistance
integrated discrimination improvement
intensive care
intensive care unit
intention-to-treat
interaction term analysis
interatrial
interatrial shunt
interatrial shunting
international right heart foundation working group
interquartile range
interventricular
interventricular septum
intestinal
intracellular
intraclass correlation coefficient
intramuscular testosterone supplementation
intravenous
intravenous bolus
intravenously
invasive
invasively
inverse correlation
ischaemia
isoforms
isolated coronary artery bypass grafting
japan
jehovah's witness
joanna briggs institute
jugular
kaiser permanente
kansas city
kaplan-meier analyses
kappa coefficients
kidney disease
kinase
kinase-2
l-type ca2(+) current
l-type ca2+ currents
l-type channel
l-type currents
l-type voltage-gated ca(2+) channels
leaflet
lean mass quantification
left anterior descending artery
left atrial area
left bundle-branch block
left pulmonary artery
left ventricle end-diastolic pressure
left ventricular diastolic function
left ventricular dilatation
left ventricular ejection time
left ventricular end-diastolic pressure
left ventricular function
left ventricular hypertrophy
left ventricular systolic dysfunction
lesions
leu3
leukocytes
likelihood ratio
linear mixed models
linear models
lipid
lipoprotein
liver
liver-specific irs1 and irs2 double-knockout
log rank
log-rank testing
logistic regression
lokomat
longitudinal
lung
lv assist device implantations
lv diastolic stiffness
lv ef
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic volume
lv end-systolic volume
lv filling pressure
lv filling pressures
lv fractional shortening
lv function
lv internal diameter
lv mass
lv posterior wall
lv relaxation
lv reverse remodeling
lv strain
lv strain rate
magnet
mass spectrometric analysis
maximal ventricular power index
maximum oxygen consumption
medical history
medical outcomes study short-form
medically
medicines
mena deletion
mena expression
mesenchymal
meta-analyses
meta-analysis
meta-analyzed
michigan
microembolization
mild hf
minimal detectable change
minnesota quality of life
mis
mitochondrial complex v activity
mitochondrial oxidative phosphorylation capacity
mitochondrial proteome
mitral annular velocity
mitral annulus velocities
mitral annulus velocity
mitral leaflet motions
mitral valve area
mixed linear models
mixed models
mixed-methods study
mlhf questionnaire
morbidities
morpholino-based
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multivariable adjustment
multivariable analysis
multivariable logistic analysis
multivariable models
multivariable regression
multivariate analyses
multivariate analysis
multivariate cox model
multivariate cox proportional hazards regression modeling
multivariate cox regression analyses
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
muscle
muscles
muscular
myocardial tissue
myocardial washout
myocyte-specific mena overexpression
myofibrillar
myosin
myxoma
n-terminal pro-b-type natriuretic peptides
n-terminal pro-brain-type natriuretic peptide
n2bus
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
nanog
nanomolar
narrow qrs complex
national cardiovascular disease registry practice innovation and clinical excellence registry
natremia
natriuretic
neprilysin
neuro-hormonal
neurohormonal
neurohormonally
neurohumoral
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association classes
new york heart association classification
new zealand
no
non-cachectic chf
non-invasively
noncardiovascular
nondiabetic
noninvasive
nonischemic
nonischemic cardiomyopathies
nonmitochondrial
nonmitochondrial protein
nonprescribing
nonsignificant
nonterminal epitopes
nontrastuzumab users
north america
northern california
nosignificant
nris
nt-pro bnp
nuclear factor of activated t cells
nuclear factor-κb
nurse practitioner
nyha class
nyha class iii
nyha functional class iii
nyha-ii
nyha-iii
observational cohort studies
observational cohort study
odds ratios
oedema
ontario
operation
operations
operative
or
oral
orally
organ
organ failure
organic
out-patient
outcome
outcomes
p value
p values
p-value
p.arg83gly
p3 prolapse
p38
p38alpha
p38α
p70s6k
p70s6k-ser(411)
paf-acetylhydrolase
paf-cpt
palliation
palliative care
parasympathetic
partial pressure of end-tidal co2
pathobiology
pathogenesis
pathological
pathology
patient
paucity
pde
pde2 inhibition
pdrelated
peak early diastolic mitral annular velocity
peak early diastolic mitral flow velocity
peak o2
peak oxygen uptake
peak quadriceps force
peak respiratory quotient
peak work rate
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
perfusion
periodic breathing
perioperative
peripheral edema
peripheral muscle
pharmacological
phenotype
phenotypes
phosphomimic
physical
physical examination
physical therapy
physio ring 30
physiologic
physiological
physiology
pkc-βii-ser(660)
placebo
plasma b-type natriuretic peptide
plasma n-terminal pro-b-type natriuretic peptide
pluripotency marker
point of care
point-of-care
polymerase ii
polymorphism
polytetrafluoroethylene
post hoc analysis
post-lvad ai
postcontrast t1
postmenopausal
postoperative
postoperatively
postsystolic function
power spectral analysis
preoperative
prescribed
prescribing
prescription
preserved ef
preserved left ventricular ejection fraction
preserved left ventricular ejection fractions
preserved lv ejection fraction
preserved lvef
pressure volume relation
pressure-overload
prevalence
primary composite endpoint
primary end point
primary outcome
primary outcomes
pro bnp
pro-b-type natriuretic peptide
pro-b-type natriuretic peptides
pro-b-type np
pro2
pro6
pro75
proangiogenic
proanp
probnp
prodrug
progenitor
progenitor cells
progenitors
prognosis
prognostic
prognostically
proof-of-principle cohort study
propensity score
propensity-score
prospective
prospective studies
prospective study
prospectively
protein kinase a
protein kinase r-like er kinase
protein-c
proteolysis
proteomic
psychometric
psychosocial
pulmonary artery systolic pressure
pulse
pulse-wave
qrs duration
qt interval
quality-of-life
r
rac1
rac2
radiological
raf-mek1/2-erk1/2 signalling pathway
raft
random-effects models
randomised
randomised-controlled trials
randomization
randomize
randomized
rankin score
ras-blocker
rate ratio
receptor
red blood cell
red blood cell transfusion
reduced ef
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression analysis
regression line
regression modeling
regression models
relative risk
renal optimization strategies evaluation
renin
renin inhibitors
renin- angiotensin-aldosterone pathway
renin-angiotensin-aldosteron
renin-angiotensin-aldosterone system inhibitors
reoperation
reperfusion
repolarization
respiratory gas analysis
resting tension
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
resynchronization-defibrillation for ambulatory heart failure trial
retrospective cohort
retrospective cohort study
retrospective matched cohort study
reverse
rheumatic
rheumatoid
rhythm control
right atrial
right ventricle
right ventricular assist device
right ventricular assist devices
right ventricular contractile function
right ventricular end-diastolic area index
right ventricular fractional area
right ventricular function
right ventricular pacing
right ventricular pressure overload
right ventricular-pulmonary arterial coupling
rna
rotterdam study
rs10927887
rv function
rv support
rvad
s'
s12884
s1pr1 agonist
s3991
sarcopenic range muscle wasting
scaffold proteins
schfi v.6.2
sd of all qt intervals
sd of rr intervals
seattle
secondary end point
secondary end points
secondary endpoints
secondary outcome
secondary outcomes
selective beta-blockers
selective β-blocker
self-care of heart failure index version 6.2
sensitivity
ser96
serum albumin
serum creatinine
severe heart failure
severe hf
severe systolic heart failure
severe systolic hf
short-term fractal scaling exponent
shotgun lc-ms/ms
shunt
shunting
shuttle walk test
signal transduction
signaling pathway
signaling pathways
signalling pathway
signalling pathways
significance
significant
significantly
smad 2/3
spearman correlations
specificity
speckle tracking echocardiography
sphingosine-1-phosphate receptor 1
spontaneous ventricular tachycardia
spontaneous vt
stable
stable heart failure
stable hf
standard error of measurement
stenosis
sternal
sternotomy
stress doppler echocardiography
stroke volume index
structured telephone support
student t test
subcellular
subclinical
subproteome
subproteomes
surgeons
surgically
sweden
sympathetic control of heart rate
symptom
symptomatic
symptomatic adult fontan
symptomatic chronic advanced heart failure
symptomatic systolic heart failure
symptoms
syndrome
syndromes
systemic
systolic  heart failure
systolic elastance
systolic function
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic left ventricular dysfunction
systolic pressure
systolic ventricular function
systolic volume index
t1
t1 mapping
t1 time
t1 times
t2*
tachyarrhythmias
tachycardic
taub
telemonitoring
terminal
testosterone supplementation
texas
texas cancer registry–medicare
tgf-β receptor type i
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
therapeutics
therapies
third heart sound
thr197
thromboembolic
thromboembolic pulmonary hypertension
thromboembolism
thrombotic
timed up & go test
tissue doppler
tissuefaxs
titrated
tm24/7
tonometric
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
total arterial compliance
transcatheter aortic valve procedure
transduction pathways
transgenic
transient receptor potential cation channel m7
transmitral
transmitral blood flow velocity
transoesophageal echocardiographic
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin i
troponin t
trpm7
tta/tgtetmena
tug test
tumor
tumors
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
ulcers
undiagnosed
unilateral renal denervation
univariable analysis
univariate analysis
university of connecticut
uptitration
uptitrations
us
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
vascular disease
vascular diseases
vascular endothelial growth factor blockade
vascular stiffness
vasopressin type 2 receptor antagonist
vegf expression
vegf signaling pathway
ven/vco2 slope
vena cava
venous
ventricular action potential
ventricular action potentials
ventricular fibrillation
ventricular myocytes
ventricularly
vo2 max
volume overload
von willebrand factor
wall stiffness
wide qrs complex
wilcoxon matched-pairs signed-rank tests
women's health initiative
x-ray
yorkshire
z-score
zung self-rated depression scores
β coefficient
β-adrenergic receptor blockade
β-adrenergic receptor blocker
β1ar
